BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 27624182)

  • 1. Manipulation of the host cell membrane by human γ-herpesviruses EBV and KSHV for pathogenesis.
    Wei F; Zhu Q; Ding L; Liang Q; Cai Q
    Virol Sin; 2016 Oct; 31(5):395-405. PubMed ID: 27624182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EBV and KSHV Infection Dysregulates Autophagy to Optimize Viral Replication, Prevent Immune Recognition and Promote Tumorigenesis.
    Cirone M
    Viruses; 2018 Oct; 10(11):. PubMed ID: 30384495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How Epstein-Barr Virus and Kaposi's Sarcoma-Associated Herpesvirus Are Maintained Together to Transform the Same B-Cell.
    Sugden AU; Hayes M; Sugden B
    Viruses; 2021 Jul; 13(8):. PubMed ID: 34452344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lytic cycle switches of oncogenic human gammaherpesviruses.
    Miller G; El-Guindy A; Countryman J; Ye J; Gradoville L
    Adv Cancer Res; 2007; 97():81-109. PubMed ID: 17419942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent KSHV Infection Increases EBV-Associated Tumor Formation In Vivo via Enhanced EBV Lytic Gene Expression.
    McHugh D; Caduff N; Barros MHM; Rämer PC; Raykova A; Murer A; Landtwing V; Quast I; Styles CT; Spohn M; Fowotade A; Delecluse HJ; Papoudou-Bai A; Lee YM; Kim JM; Middeldorp J; Schulz TF; Cesarman E; Zbinden A; Capaul R; White RE; Allday MJ; Niedobitek G; Blackbourn DJ; Grundhoff A; Münz C
    Cell Host Microbe; 2017 Jul; 22(1):61-73.e7. PubMed ID: 28704654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonsense-mediated decay controls the reactivation of the oncogenic herpesviruses EBV and KSHV.
    van Gent M; Reich A; Velu SE; Gack MU
    PLoS Biol; 2021 Feb; 19(2):e3001097. PubMed ID: 33596193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective switch between latency and lytic replication of Kaposi's sarcoma herpesvirus and Epstein-Barr virus in dually infected body cavity lymphoma cells.
    Miller G; Heston L; Grogan E; Gradoville L; Rigsby M; Sun R; Shedd D; Kushnaryov VM; Grossberg S; Chang Y
    J Virol; 1997 Jan; 71(1):314-24. PubMed ID: 8985352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [EBV/KSHV co-infection: an effective partnership].
    Gruffat H; Manet E
    Med Sci (Paris); 2018 Jan; 34(1):79-82. PubMed ID: 29384100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. K1 and K15 of Kaposi's Sarcoma-Associated Herpesvirus Are Partial Functional Homologues of Latent Membrane Protein 2A of Epstein-Barr Virus.
    Steinbrück L; Gustems M; Medele S; Schulz TF; Lutter D; Hammerschmidt W
    J Virol; 2015 Jul; 89(14):7248-61. PubMed ID: 25948739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus inhibits Kaposi's sarcoma-associated herpesvirus lytic replication in primary effusion lymphomas.
    Xu D; Coleman T; Zhang J; Fagot A; Kotalik C; Zhao L; Trivedi P; Jones C; Zhang L
    J Virol; 2007 Jun; 81(11):6068-78. PubMed ID: 17376914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of the KSHV and EBV lytic cycles to tumourigenesis.
    Manners O; Murphy JC; Coleman A; Hughes DJ; Whitehouse A
    Curr Opin Virol; 2018 Oct; 32():60-70. PubMed ID: 30268927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pentameric protein ring with novel architecture is required for herpesviral packaging.
    Didychuk AL; Gates SN; Gardner MR; Strong LM; Martin A; Glaunsinger BA
    Elife; 2021 Feb; 10():. PubMed ID: 33554858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Lytic Infection for Lymphomagenesis of Human γ-Herpesviruses.
    Münz C
    Front Cell Infect Microbiol; 2021; 11():605258. PubMed ID: 33842383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KSHV LANA and EBV LMP1 induce the expression of UCH-L1 following viral transformation.
    Bentz GL; Bheda-Malge A; Wang L; Shackelford J; Damania B; Pagano JS
    Virology; 2014 Jan; 448():293-302. PubMed ID: 24314660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Epstein-Barr virus (EBV) and Kaposi's sarcoma-associated herpesvirus (KSHV, HHV-8)].
    Katano H
    Uirusu; 2010 Dec; 60(2):237-45. PubMed ID: 21488336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The oncogenic gamma herpesviruses Epstein-Barr virus (EBV) and Kaposi's sarcoma-associated herpesvirus (KSHV) hijack retinoic acid-inducible gene I (RIG-I) facilitating both viral and tumour immune evasion.
    Nash A; Ryan EJ
    Tumour Virus Res; 2022 Dec; 14():200246. PubMed ID: 35998812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 25-Hydroxycholesterol Inhibits Kaposi's Sarcoma Herpesvirus and Epstein-Barr Virus Infections and Activates Inflammatory Cytokine Responses.
    Serquiña AKP; Tagawa T; Oh D; Mahesh G; Ziegelbauer JM
    mBio; 2021 Dec; 12(6):e0290721. PubMed ID: 34781692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chloroquine inhibits lytic replication of Kaposi's sarcoma-associated herpesvirus by disrupting mTOR and p38-MAPK activation.
    Yang M; Huang L; Li X; Kuang E
    Antiviral Res; 2016 Sep; 133():223-33. PubMed ID: 27521848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation and repression of Epstein-Barr Virus and Kaposi's sarcoma-associated herpesvirus lytic cycles by short- and medium-chain fatty acids.
    Gorres KL; Daigle D; Mohanram S; Miller G
    J Virol; 2014 Jul; 88(14):8028-44. PubMed ID: 24807711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of Epstein-Barr virus, cytomegalovirus, and Kaposi's sarcoma-associated herpesvirus infections in peripheral blood leukocytes revealed by a multiplex PCR assay.
    Nishiwaki M; Fujimuro M; Teishikata Y; Inoue H; Sasajima H; Nakaso K; Nakashima K; Sadanari H; Yamamoto T; Fujiwara Y; Ogawa N; Yokosawa H
    J Med Virol; 2006 Dec; 78(12):1635-42. PubMed ID: 17063511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.